Ciprofloxacin Lactate
CAS number: 97867-33-9
Molecular formula: C20H24FN3O6
molecular weight: 421.42
Chemical structure:
Producers shown on SFDA
(Record date:02/11/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Xinchang Hebao Biotechnology Co., Ltd. | GMP | Valid till February 2026 |
Shangyu Jingxin Pharmaceutical Co., Ltd. | GMP | Valid till December 2023 |
Shijiazhuang Liwei Veterinary Drug Factory | GMP | Valid till April 2023 |
Jiaozuo Kaisen Pharmaceutical Co., Ltd. | GMP | Valid till September 2021 |
Luoyang Huizhong Animal Medicine Co., Ltd. | GMP | Valid till June 2021 |
Producers shown on EP
Not showing any
Producer:Xinchang Hebao Biotechnology Co., Ltd., established in 1999, is a subsidiary of Guobang Pharmaceutical Group Co., Ltd. The company takes animal protection raw materials and preparations as the leading industry, and is mainly engaged in the R & D, production and sales of animal protection raw materials, animal protection solid preparations and feed additives. The company has core technologies such as microcapsule dispersion, spray drying, masking, coating, fluidized drying, boiling granulation, dissolution and instant dissolution, controlled release and so on. It has more than ten production lines focusing on powder, premix, powder and feed additives; It has 3 categories of products, including 88 approvals for animal protection APIs, animal protection preparations and feed additives. All products of the company have passed the domestic GMP certification.
Staff size:100-199 persons
Registered capital:RMB 20 million
Website: http://www.hebaobio.com
Producer:Shangyu Jingxin Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Zhejiang Jingxin Pharmaceutical Co., Ltd. Zhejiang Jingxin Pharmaceutical Co., Ltd. is one of the top 100 pharmaceutical enterprises in China and a listed pharmaceutical company. The company is located in the West Zone of Shangyu Industrial Park, Hangzhou Bay, Zhejiang Province. Its products are mainly the production of APIs. It is one of the largest production bases of quinolone APIs in China“ Cyclopropyl hydrochloride and levofloxacin hydrochloride occupy a large market share in China. API products sell well in Southeast Asia, South Asia, Latin America, Europe and other international markets.
The company has fully passed the national GMP certification, ISO14001 certification, simvastatin has obtained cos certificate, ciprofloxacin hydrochloride has obtained cos certificate, French GMP certificate, EU GMP certificate and KFDA registration certificate.
Staff size:500-599 persons
Registered capital:RMB 150 million
Website: https://www.jingxinpharm.com
Producer:Shijiazhuang Liwei Veterinary Drug Factory is a professional and modern veterinary drug and veterinary drug raw material production enterprise integrating veterinary drug development, production and operation. It now has a GMP standard API production workshop and powder / premix / powder production workshop of the Ministry of agriculture. It passed the veterinary drug GMP certification of the Ministry of agriculture at one time in 2006.
Staff size:About 50 people
Registered capital:RMB 20.3 million
Website: website not found
Producer:Jiaozuo Kaisen Pharmaceutical Co., Ltd. was founded in 2006, covering an area of more than 50000 square meters. It has newly built a powder injection production line, three water injection production lines, five solid production lines, two disinfectant production lines, doxycycline raw material production line and traditional Chinese medicine extraction production line. It will achieve an annual production capacity of 10 million bags of veterinary powder, 100 million pieces of water injection and powder injection, 500000 bottles of disinfectant and 450 tons of doxycycline API.
Staff size:/
Registered capital:RMB 15 million
Website: website not found
Producer:Luoyang Huizhong Animal Medicine Co., Ltd., established in 1995, is a wholly-owned subsidiary of Pleco Bioengineering Co., Ltd.
The company's GMP production base has 15 production lines and 3 API production qualifications, and its production capacity ranks in the forefront of the industry.
Staff size:200-299 people
Registered capital:RMB 50 million
Website: http://www.huizhongsy.com.cn
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978